Saline Nasal Mist ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
127	前頭側頭葉変性症	2

127. 前頭側頭葉変性症

---

臨床試験数 : 89 /  薬物数 : 104 - (DrugBank : 33) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 117

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01937013 (ClinicalTrials.gov)	September 12, 2013	3/9/2013	Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia	Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia	Frontotemporal Dementia	Drug: Intranasal oxytocin;Drug: Saline Nasal Mist	Lawson Health Research Institute	Canadian Institutes of Health Research (CIHR)	Completed	30 Years	85 Years	All	52	Phase 2	Canada
2	NCT01386333 (ClinicalTrials.gov)	June 2011	29/6/2011	Safety Study of Intranasal Oxytocin in Frontotemporal Dementia	A Phase I Dose Finding Study of Intranasal Oxytocin in Frontotemporal Dementia, Protocol # FTDOXY10EF	Frontotemporal Dementia	Drug: oxytocin;Drug: Saline Nasal Mist	Lawson Health Research Institute	The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)	Completed	30 Years	80 Years	Both	23	Phase 1	Canada